XIFIN Partners with Translational Software to Provide Pharmacogenetic Testing Interpretation for Improved Health Outcomes

XIFIN, Inc., the healthcare cloud computing company revolutionizing the business of healthcare diagnostics from patient to payment, today announced it has entered into an agreement with Translational Software®, a leader in integrating genetic information into routine clinical care, to market its end-to-end pharmacogenetic (PGx) knowledge solutions to support customers involved in PGx testing and personalized medicine initiatives.

Please to read the entire article.